Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
28.55
Dollar change
+0.13
Percentage change
0.46
%
IndexRUT P/E10.87 EPS (ttm)2.63 Insider Own22.79% Shs Outstand6.89M Perf Week-5.96%
Market Cap200.71M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.43M Perf Month-41.09%
Income20.58M PEG- EPS next Q1.33 Inst Own50.64% Short Float4.00% Perf Quarter-37.06%
Sales68.18M P/S2.94 EPS this Y68.06% Inst Trans39.03% Short Ratio2.88 Perf Half Y7.86%
Book/sh10.43 P/B2.74 EPS next Y- ROA29.24% Short Interest0.22M Perf Year8.76%
Cash/sh8.16 P/C3.50 EPS next 5Y- ROE32.29% 52W Range21.18 - 53.38 Perf YTD-35.54%
Dividend Est.- P/FCF11.81 EPS past 5Y31.99% ROI28.64% 52W High-46.52% Beta0.92
Dividend TTM- Quick Ratio10.56 Sales past 5Y26.97% Gross Margin89.76% 52W Low34.80% ATR (14)2.28
Dividend Ex-Date- Current Ratio10.64 EPS Y/Y TTM43.68% Oper. Margin33.72% RSI (14)25.41 Volatility4.73% 8.42%
Employees92 Debt/Eq0.00 Sales Y/Y TTM20.28% Profit Margin30.19% Recom1.00 Target Price65.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q34.37% Payout0.00% Rel Volume0.99 Prev Close28.42
Sales Surprise3.83% EPS Surprise-24.66% Sales Q/Q9.15% EarningsMar 05 AMC Avg Volume75.40K Price28.55
SMA20-17.35% SMA50-31.36% SMA200-15.75% Trades Volume75,004 Change0.46%
Date Action Analyst Rating Change Price Target Change
Nov-02-22Downgrade B. Riley Securities Buy → Neutral $60 → $45
Mar-07-24 01:57PM
09:38AM
Mar-05-24 08:51PM
04:01PM
Feb-21-24 08:03AM
11:14AM Loading…
Feb-19-24 11:14AM
Nov-11-23 10:48AM
Nov-09-23 04:01PM
Oct-26-23 04:01PM
Sep-14-23 01:08PM
Aug-31-23 04:01PM
Aug-10-23 04:01PM
Jul-28-23 08:03AM
Jul-11-23 08:03AM
Jun-23-23 04:01PM
04:01PM Loading…
May-10-23 04:01PM
May-01-23 04:01PM
Apr-28-23 04:01PM
Apr-19-23 04:01PM
Apr-05-23 08:03AM
Apr-03-23 08:01AM
Mar-21-23 04:05PM
04:01PM
Mar-10-23 08:03AM
Mar-01-23 04:01PM
Dec-14-22 08:03AM
Dec-12-22 08:05AM
Nov-01-22 04:01PM
Oct-19-22 04:01PM
Aug-31-22 08:03AM
06:35AM Loading…
Aug-16-22 06:35AM
Aug-02-22 04:01PM
Jul-21-22 08:03AM
Jun-30-22 07:48AM
May-23-22 10:31AM
May-05-22 10:10AM
May-02-22 07:15PM
04:01PM
Apr-19-22 08:03AM
Apr-07-22 08:03AM
Mar-30-22 03:43PM
Mar-14-22 04:01PM
Mar-01-22 08:01AM
Feb-28-22 04:01PM
12:38PM
Feb-17-22 08:03AM
Jan-25-22 05:38PM
Jan-21-22 08:59AM
Jan-19-22 09:38AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 10:58AM
09:38AM
Dec-08-21 09:38AM
Nov-01-21 04:01PM
Oct-22-21 08:03AM
Oct-15-21 06:58AM
Sep-30-21 12:40PM
Sep-27-21 08:03AM
Sep-06-21 08:46AM
Aug-27-21 09:19AM
09:18AM
08:45AM
Aug-26-21 08:03AM
Aug-17-21 10:08AM
Aug-02-21 07:25PM
04:01PM
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEMLER ERICDirectorSep 13 '23Buy28.1126,868755,25977,771Sep 13 07:05 PM
SEMLER ERICDirectorSep 12 '23Buy27.7025,903717,51350,903Sep 13 07:05 PM
SEMLER ERICDirectorSep 11 '23Buy26.9825,000674,50025,000Sep 13 07:05 PM